Research location
North Las Vegas
Nevada, United States
Advertisement
Research activity in North Las Vegas
Nevada, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 29 trials and 29 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in North Las Vegas
29 linked trials · page 1 of 1EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation
RECRUITING
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionNCT06307652 · 2024-04-12 · 1 site observation
RECRUITING
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEMNCT06378632 · 2022-02-11 · 1 site observation
RECRUITING
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)NCT06098079 · 2024-01-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionNCT05968430 · 2023-07-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)NCT05813288 · 2023-03-27 · 1 site observation
TERMINATED
A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)NCT05755906 · 2023-02-27 · 1 site observation
COMPLETED
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidNCT05292586 · 2022-08-31 · 1 site observation
COMPLETED
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)NCT05202262 · 2022-01-12 · 1 site observation
COMPLETED
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)NCT04636814 · 2021-07-12 · 1 site observation
TERMINATED
Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 InflammationNCT04773678 · 2021-05-11 · 1 site observation
COMPLETED
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)NCT04609904 · 2021-03-01 · 1 site observation
COMPLETED
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)NCT03888066 · 2019-04-24 · 1 site observation
COMPLETED
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00327015 · 2006-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.NCT00328627 · 2006-05-01 · 1 site observation
COMPLETED
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasNCT00313313 · 2006-04-01 · 1 site observation
COMPLETED
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneNCT00295633 · 2006-03-01 · 1 site observation
COMPLETED
A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01 · 1 site observation
COMPLETED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusNCT00226330 · 2005-03-01 · 1 site observation
TERMINATED
GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 DiabetesNCT00229710 · 2005-02-01 · 1 site observation
TERMINATED
GALLANT 9 Tesaglitazar vs. Placebo in Combination With InsulinNCT00242372 · 2004-08-01 · 1 site observation
TERMINATED
Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusNCT00762736 · 2004-07-01 · 1 site observation
COMPLETED
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With AsthmaNCT00139659 · 2003-01-01 · 1 site observation
COMPLETED
Safety and Tolerability Study of Drug to Treat SchizophreniaNCT00044005 · 2002-09-01 · 1 site observation
COMPLETED
A Comparison of Study Drug With Placebo and Haloperidol in Patients With SchizophreniaNCT00044044 · 2002-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.